EVOK icon

Evoke Pharma

12 hedge funds and large institutions have $228K invested in Evoke Pharma in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12

77% less capital invested

Capital invested by funds: $987K → $228K (-$759K)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$39K
Puts
$17K
Net Calls
Net Calls Change

Top Buyers

1 +$12.1K
2 +$7.43K
3 +$5K
4
Citigroup
Citigroup
New York
+$3K
5
Group One Trading
Group One Trading
Illinois
+$2K

Top Sellers

1 -$201K
2 -$54K
3 -$41K
4
CC
Cornerstone Capital
California
-$33K
5
BlackRock
BlackRock
New York
-$21.2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$102K
2
$67K
3
$27K
4
$19K
5
$8K
6
$3K
7
$2K
8
$16
9
10
11
12
13
14
15
16
17
18
19
20